According to research report the global spinal implants market is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in 2019, at a CAGR of 5.0%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712
Market Growth Factors –
Advancements
in spine surgery technologies, increasing incidence of spinal
disorders, the launch of advanced bone grafting products, and the
increasing adoption of minimally invasive spine surgeries are the major
factors driving the growth of this segment.
Geographic Overview-
The
Asia Pacific spinal implants market is estimated to grow at the highest
CAGR during the forecast period. This can be attributed to the
improving healthcare infrastructure, rising awareness, improving
reimbursement scenario, and the growing insurance coverage in several
APAC countries.
Top Segments-
Based on technology the spinal
implants and surgical devices market, the spinal fusion and fixation
technologies segment accounted for the largest market share in 2019.
Based
on technology, the spinal implants market is segmented into spinal
fusion and fixation, vertebral compression fracture treatment, motion
preservation/non-fusion, and spinal decompression technologies. The
spinal fusion and fixation technologies segment accounted for the
largest share of the market in 2019.
By product, the thoracic
fusion & lumbar fusion devices segment accounted for the largest
spinal implants and surgical devices market share in 2019.
Based
on product, the spinal implants market is segmented into thoracic fusion
and lumbar fusion devices, cervical fusion devices, spine biologics,
non-fusion devices, vertebral compression fracture treatment devices,
spinal decompression devices, and spine bone stimulators. The thoracic
fusion and lumbar fusion devices segment accounted for the largest share
of the spinal implants and surgical devices market.
The open surgeries segment will continue to dominate the spinal implants market in 2025.
Request Free Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=712
Recent Developments –
>
In 2020, Medtronic (Ireland) acquired Stimgenics, a US-based, privately
held company that has pioneered a novel spinal cord stimulation (SCS).
> In 2019, DePuy Synthes (US) launched Symphony Occipitocervico-thoracic System.
> In 2019, NuVasive (US) launched Modulus TLIF-O.
>
In 2018, NuVasive (US) and Biedermann Motech GmbH & Co. KG
(Germany) entered into a strategic partnership to access intellectual
properties and co-develop state-of-the-art complex spine solutions.
> In 2018, Stryker Corporation (US) launched ProChondrix CR.
